SUPERNUS PHARMACEUTICALS, INC. Investment Income, Interest
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported Investment Income, Interest of $3.26 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2020-11-06
- SUPERNUS PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2020-09-30 was $3.26M, a 41.32% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2020-06-30 was $4.15M, a 23.81% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2019-09-30 was $5.56M, a 24.61% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2019-06-30 was $5.45M, a 48.69% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. investment income, interest for fiscal 2018 was $13.84M, a 383.34% increase from fiscal 2017.
- SUPERNUS PHARMACEUTICALS, INC. investment income, interest for fiscal 2017 was $2.86M, a 95.23% increase from fiscal 2016.
- SUPERNUS PHARMACEUTICALS, INC. investment income, interest for fiscal 2016 was $1.47M, a 115.42% increase from fiscal 2015.
- SUPERNUS PHARMACEUTICALS, INC. investment income, interest for fiscal 2015 was $681.00K, a 95.69% increase from fiscal 2014.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 9 month as first filed | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-09-30 | $3.26M 10-Q · filed 2020-11-06 | $7.41M derived: sum of 2 quarters · filed 2020-11-06 | $12.99M 10-Q · filed 2020-11-06 | |||||
| 2020-06-30 | $4.15M 10-Q · filed 2020-08-17 | $9.73M 10-Q · filed 2020-08-17 | ||||||
| 2019-09-30 | $5.56M 10-Q · filed 2020-11-06 | $11.01M derived: sum of 2 quarters · filed 2020-11-06 | $15.70M 10-Q · filed 2020-11-06 | |||||
| 2019-06-30 | $5.45M 10-Q · filed 2020-08-17 | $10.14M 10-Q · filed 2020-08-17 | ||||||
| 2018-12-31 | $4.51M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $8.97M derived: sum of 2 quarters · filed 2019-03-01 | $12.64M derived: sum of 3 quarters · filed 2019-03-01 | $13.84M 10-K · filed 2019-03-01 | ||||
| 2018-09-30 | $4.46M 10-Q · filed 2018-11-09 | $8.13M derived: sum of 2 quarters · filed 2018-11-09 | $9.33M 10-Q · filed 2018-11-09 | $10.19M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2018-06-30 | $3.66M 10-Q · filed 2018-08-09 | $4.87M 10-Q · filed 2018-08-09 | $5.73M derived: sum of 3 quarters · filed 2019-03-01 | $6.55M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2018-03-31 | $1.21M 10-Q · filed 2018-05-10 | $2.07M derived: sum of 2 quarters · filed 2019-03-01 | $2.88M derived: sum of 3 quarters · filed 2019-03-01 | $3.54M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-12-31 | $862.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $1.68M derived: sum of 2 quarters · filed 2019-03-01 | $2.33M derived: sum of 3 quarters · filed 2019-03-01 | $2.86M 10-K · filed 2019-03-01 | ||||
| 2017-09-30 | $814.00K 10-Q · filed 2018-11-09 | $1.47M derived: sum of 2 quarters · filed 2018-11-09 | $2.00M 10-Q · filed 2018-11-09 | $2.40M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | $656.00K 10-Q · filed 2018-08-09 | $1.19M 10-Q · filed 2018-08-09 | $1.58M derived: sum of 3 quarters · filed 2019-03-01 | $1.96M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | $531.00K 10-Q · filed 2018-05-10 | $927.00K derived: sum of 2 quarters · filed 2019-03-01 | $1.30M derived: sum of 3 quarters · filed 2019-03-01 | $1.67M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | $396.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $774.00K derived: sum of 2 quarters · filed 2019-03-01 | $1.14M derived: sum of 3 quarters · filed 2019-03-01 | $1.47M 10-K · filed 2019-03-01 | $1.48M 10-K · filed 2017-03-16 | |||
| 2016-09-30 | $378.00K 10-Q · filed 2017-11-09 | $379.00K 10-Q · filed 2017-01-20 | $743.00K derived: sum of 2 quarters · filed 2017-11-09 | $1.07M 10-Q · filed 2017-11-09 | $1.07M 10-Q · filed 2017-01-20 | $1.33M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-06-30 | $365.00K 10-Q · filed 2017-08-03 | $363.00K 10-Q · filed 2016-08-05 | $693.00K 10-Q · filed 2017-08-03 | $694.00K 10-Q · filed 2016-08-05 | $954.00K derived: sum of 3 quarters · filed 2018-03-01 | $1.12M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-03-31 | $327.00K 10-Q · filed 2017-05-09 | $331.00K 10-Q · filed 2016-05-10 | $589.00K derived: sum of 2 quarters · filed 2018-03-01 | $758.00K derived: sum of 3 quarters · filed 2018-03-01 | $895.00K derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $262.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | $431.00K derived: sum of 2 quarters · filed 2018-03-01 | $568.00K derived: sum of 3 quarters · filed 2018-03-01 | $681.00K 10-K · filed 2018-03-01 | $643.00K 10-K · filed 2016-03-09 | |||
| 2015-09-30 | $169.00K 10-Q/A · filed 2017-01-20 | $306.00K derived: sum of 2 quarters · filed 2017-01-23 | $419.00K 10-Q/A · filed 2017-01-20 | $502.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | $137.00K 10-Q/A · filed 2017-01-23 | $250.00K 10-Q/A · filed 2017-01-23 | $333.00K derived: sum of 3 quarters · filed 2017-03-16 | $411.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | $113.00K 10-Q/A · filed 2017-01-20 | $196.00K derived: sum of 2 quarters · filed 2017-03-16 | $274.00K derived: sum of 3 quarters · filed 2017-03-16 | $359.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | $83.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-03-16 | $161.00K derived: sum of 2 quarters · filed 2017-03-16 | $246.00K derived: sum of 3 quarters · filed 2017-03-16 | $348.00K 10-K · filed 2017-03-16 | ||||
| 2014-09-30 | $78.00K 10-Q/A · filed 2017-01-20 | $163.00K derived: sum of 2 quarters · filed 2017-01-20 | $265.00K 10-Q/A · filed 2017-01-20 | $361.00K derived: sum of 4 quarters · filed 2017-01-20 | ||||
| 2014-06-30 | $85.00K 10-Q · filed 2015-08-07 | $187.00K 10-Q · filed 2015-08-07 | $283.00K derived: sum of 3 quarters · filed 2017-01-20 | $379.00K derived: sum of 4 quarters · filed 2017-01-20 | ||||
| 2014-03-31 | $102.00K 10-Q · filed 2015-05-06 | $198.00K derived: sum of 2 quarters · filed 2017-01-20 | $294.00K derived: sum of 3 quarters · filed 2017-01-20 | $349.00K derived: sum of 4 quarters · filed 2017-01-20 | ||||
| 2013-12-31 | $96.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-01-20 | $192.00K derived: sum of 2 quarters · filed 2017-01-20 | $247.00K derived: sum of 3 quarters · filed 2017-01-20 | $299.00K 10-K/A · filed 2017-01-20 | ||||
| 2013-09-30 | $96.00K 10-Q · filed 2014-11-12 | $151.00K derived: sum of 2 quarters · filed 2014-11-12 | $203.00K 10-Q · filed 2014-11-12 | $232.00K derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | $55.00K 10-Q · filed 2014-08-12 | $107.00K 10-Q · filed 2014-08-12 | $136.00K derived: sum of 3 quarters · filed 2015-03-12 | $175.00K derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | $52.00K 10-Q · filed 2014-05-13 | $81.00K derived: sum of 2 quarters · filed 2015-03-12 | $120.00K derived: sum of 3 quarters · filed 2015-03-12 | $152.00K derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $68.00K derived: sum of 2 quarters · filed 2015-03-12 | $100.00K derived: sum of 3 quarters · filed 2015-03-12 | $120.00K 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | $39.00K 10-Q · filed 2013-11-13 | $71.00K derived: sum of 2 quarters · filed 2013-11-13 | $91.00K 10-Q · filed 2013-11-13 | $92.00K derived: sum of 4 quarters · filed 2014-03-21 | ||||
| 2012-06-30 | $32.00K 10-Q · filed 2013-08-14 | $52.00K 10-Q · filed 2013-08-14 | $53.00K derived: sum of 3 quarters · filed 2014-03-21 | $56.00K derived: sum of 4 quarters · filed 2014-03-21 | ||||
| 2012-03-31 | $19.00K 10-Q · filed 2013-05-15 | $21.00K derived: sum of 2 quarters · filed 2014-03-21 | $24.00K derived: sum of 3 quarters · filed 2014-03-21 | $36.00K derived: sum of 4 quarters · filed 2014-03-21 | ||||
| 2011-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $5.00K derived: sum of 2 quarters · filed 2014-03-21 | $17.00K derived: sum of 3 quarters · filed 2014-03-21 | $31.00K 10-K · filed 2014-03-21 | ||||
| 2011-09-30 | $3.00K 10-Q · filed 2012-11-02 | $15.00K derived: sum of 2 quarters · filed 2012-11-02 | $29.00K 10-Q · filed 2012-11-02 | |||||
| 2011-06-30 | $12.00K 10-Q · filed 2012-08-13 | $27.00K 10-Q · filed 2012-08-13 | ||||||
| 2011-03-31 | $15.00K 10-Q · filed 2012-06-08 | |||||||
| 2010-12-31 | $107.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |